Ariel Altaba-Ruiz

Geneve, GE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Emergence of high-metastatic potentials and prediction of recurrence and metastasis.

Emergence of high-metastatic potentials and prediction of recurrence and metastasis.

Journal: Cell reports
Published: June 17, 2025

Emergence of high-metastatic potentials and prediction of recurrence and metastasis.

Emergence of high-metastatic potentials and prediction of recurrence and metastasis.

Journal: Cell reports
Published: June 17, 2025

On the origin of metastases: Induction of pro-metastatic states after impending cell death via ER stress, reprogramming, and a cytokine storm.

On the origin of metastases: Induction of pro-metastatic states after impending cell death via ER stress, reprogramming, and a cytokine storm.

Journal: Cell reports
Published: June 11, 2021

Functional Pro-metastatic Heterogeneity Revealed by Spiked-scRNAseq Is Shaped by Cancer Cell Interactions and Restricted by VSIG1.

Functional Pro-metastatic Heterogeneity Revealed by Spiked-scRNAseq Is Shaped by Cancer Cell Interactions and Restricted by VSIG1.

Journal: Cell reports
Published: February 21, 2020

Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.

Drug repurposing in oncology: Compounds, pathways, phenotypes and computational approaches for colorectal cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer
Published: February 18, 2019

Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.

Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.

Journal: Scientific reports
Published: October 30, 2018

The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.

The protein secretion modulator TMED9 drives CNIH4/TGFα/GLI signaling opposing TMED3-WNT-TCF to promote colon cancer metastases.

Journal: Oncogene
Published: September 13, 2018

Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.

Correction: Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.

Journal: PloS one
Published: August 05, 2016

Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells.

Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells.

Journal: PloS one
Published: July 18, 2016

Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.

Metastases and Colon Cancer Tumor Growth Display Divergent Responses to Modulation of Canonical WNT Signaling.

Journal: PloS one
Published: October 30, 2015

Alberto Gulino MD, PhD (1952-2014).

Alberto Gulino MD, PhD (1952-2014).

Journal: Cell death and differentiation
Published: May 06, 2015

In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases.

In vivo epigenetic reprogramming of primary human colon cancer cells enhances metastases.

Journal: Journal of molecular cell biology
Published: February 02, 2015
Showing 1-12 of 20

Last Updated: 09/26/2026